Sir, The recent article by Gosden et al. 1 prompted me to reflect on the widespread use of disc diffusion methods for determining antibiotic susceptibility that ignore an important finding of the definitive studies of Cooper 2 and Linton 3 on the formation of inhibition zones. These investigators showed that, although the intrinsic susceptibility of a bacterial isolate, under the in-vitro conditions of the test, is one parameter that influences zone diameter, of even greater importance are factors that determine the time taken for the bacterial inoculum to reach a 'critical population' density.
The disc diffusion techniques most commonly used (the Kirby-Bauer and Stokes' tests) take account of important factors, including the inoculum density, the composition of the medium, the delay between application of the disc and incubation, the temperature of incubation, etc., but the resulting zone of inhibition is then compared with that produced by a standard strain and/or predetermined templates, thereby disregarding the growth rate of the isolate being tested. In other words, these methods assume that all clinical isolates exhibit the same rate of growth in vitro as that of the control or 'average' strain.
Many years ago, I carried out studies relating to the determination of the susceptibilities of Staphylococcus aureus isolates to erythromycin by the Kirby-Bauer method. I observed that, if a fully susceptible strain with a lag phase and a generation time of 30 min each mutated to one with a lag phase of the same duration, but a generation time of 21 min, the latter would appear to be resistant to erythromycin, even though its MIC was the same as that of the parent strain; a change in the reverse direction would result in a resistant organism's appearing susceptible. Methods which overcome this difficulty by using discs containing different concentrations have been proposed, 4, 5 but have not become popular, despite requiring only slightly more effort than the techniques in common use. Although I would invert the calculations in the second method referred to above, 5 in practice, calculations are seldom needed, a simple, hand-drawn graph yielding a sufficiently accurate result. Moreover, such methods make the need to control many of the other factors associated with susceptibility testing less critical.
The preceding discussion poses an obvious question: how variable are the growth kinetics of strains isolated in clinical practice? The answer may be 'not very variable', but it is clearly not in a patient's best interests to be infected with a bacterium that is amenable to eradication by the antibiotic of choice, yet to be denied treatment with that agent because the organism appears to be resistant when susceptibility is determined by the disc diffusion method, owing to its rapid growth rate; the reverse situation is equally undesirable.
I am hopeful that my colleagues in Bristol might turn their attentions to this interesting and potentially important issue. 1 We would like to report our experience of a similar comparison with Pseudomonas aeruginosa isolates, comparing the modified Stokes' method with the MIC result obtained by the Etest. Evaluation of the Etest for antimicrobial sensitivity testing of P. aeruginosa isolates to ciprofloxacin has been shown to be reliable compared with the agar dilution method. 2, 3 One hundred and four isolates of P. aeruginosa (47 sensitive, four intermediate, and 53 strains resistant to ciprofloxacin as defined by the modified Stokes' method) from hospital in-patients and out-patients and from general practitioners were tested. The disc diffusion test with a ciprofloxacin 1 g disc was carried out using Diagnostic Sensitivity Test (DST) agar (Mast Diagnostics, Merseyside, UK) and the rotary modified Stokes' method with the control organism (P. aeruginosa NCTC 10662) on the outside and the test organism in the centre.
Interpretation of the results of sensitivity testing for the Stokes' method used the British Society for Antimicrobial Chemotherapy (BSAC) criteria, i.e. an isolate was reported as sensitive if the zone radius was equal to, wider than, or not 7 mm smaller than the control; intermediate if the zone radius was 2 mm but smaller than the control by 7 mm; and resistant if the zone radius was 2 mm. 4 The Etest (AB Biodisk, Solna, Sweden) was performed on Iso-Sensitest agar (Unipath Ltd, Basingstoke, UK) using the manufacturer's instructions. A comparison was made between the MIC result obtained by the Etest and the sensitivity result obtained from the Stoke's method. The results are given in the Table. No major errors were identified, i.e. no resistant strains were reported as sensitive. However, one minor error (i.e. sensitive strain reported as resistant) was noted using the higher BSAC set of breakpoints ( 1, 1-4 and 4 mg/L) and no errors using the lower BSAC set of breakpoints ( 0.5, 1-2 and 2 mg/L). A total of 17 isolates had an intermediate MIC, i.e. 1 and 4 mg/L (low-level resistance). In this group the greatest number of misclassifications occurred. This is perhaps to be expected, as P. aeruginosa shows a continuous distribution of MICs and does not divide into two distinct (resistant and sensitive) populations; a disc test would therefore not clearly classify isolates in the same way as an MIC test, and categorization errors do occur. 5 Overreporting of ciprofloxacin resistance for P. aeruginosa by the disc method has been previously highlighted as a particular problem by other workers. 6 Our laboratory serves a district general hospital but also houses the Regional Spinal Injuries Unit. P. aeruginosa is a frequent cause of colonization and infection in patients with spinal cord injury and we are therefore particularly interested in ensuring that ciprofloxacin sensitivity to P. aeruginosa isolates is reported accurately. The quinolones are the only effective oral anti-pseudomonal agents available and their use may allow patients who require treatment to return home rather than stay in hospital for intravenous therapy. Routine determination of MICs for all P. aeruginosa isolates in our laboratory would not be feasible. As a result of our study and because of the difficulty in reading small zone sizes, we developed a local protocol in which P. aeruginosa isolates that show a zone of inhibition to ciprofloxacin, but this radius is 3 mm, have an MIC determined using the Etest strip. This has reduced 314 the number of isolates misclassified. We would agree with Gosden et al. 1 that the modified Stokes' method for sensitivity testing may show an unacceptable number of major errors for some organisms; however, for P. aeruginosa susceptibility to ciprofloxacin we have found the modified Stokes' method to be acceptable provided its limitations are appreciated. We will be interested to compare our previous results with those obtained using the standardized disc method of sensitivity testing recommended in the BSAC Summer Newsletter, 1998. data provided by the Prescriptions Pricing Authority) are not amenable to interpretation in relation to clinical usage. None the less, there is widespread concern that the overall level of antibiotic prescribing is excessive. We recently analysed PACT data for antibiotic usage in the West Midlands and concluded that seasonal analysis might contribute to interpreting and setting targets for appropriate prescribing. Early fluoroquinolones (ciprofloxacin, ofloxacin and norfloxacin) have limited activities against pneumococci, streptococci, enterococci, anaerobes and methicillin-resistant Staphyloccocus aureus. 1 For these reasons, it is widely regarded that these drugs should not be used routinely as treatment of patients with respiratory tract, soft tissue or bone infections without clear bacteriological indications; in contrast to ciprofloxacin and ofloxacin, norfloxacin is licensed solely for use as therapy of patients with urinary tract infections.
Seasonal variation in fluoroquinolone prescribing
The administered as therapy of patients with seasonal infections, particularly those of the respiratory tract. While the quinolones have potent activities against Haemophilus influenzae, they exhibit only modest activities against pneumococci and there are several antibiotics that should be used in preference in patients with respiratory tract infections; these include the tetracyclines, co-amoxiclav, trimethroprim and second-and third-generation cephalosporins. The newer fluoroquinolones, grepafloxacin and levofloxacin, have superior activities against pneumococci, compared with earlier agents, but it should not be construed from this that either drug should be used routinely as first-line therapy.
Fluoroquinolones are used widely in both human and veterinary medicine; indeed, ciprofloxacin is currently one of the world's most frequently administered antibiotics. 2 In order to minimize the emergence of resistant strains, crossresistance being a feature of these agents, 3 they should be used rationally. Fluoroquinolones are described in the ninth World Health Organisation Model List of Essential Drugs as being among 'the most important reserve agents'. 4 Thus, the use of these antibiotics in patients with respiratory tract infections, as implied by the data reported here, and the rapid increase in ciprofloxacin prescribing in the West Midlands during 1997 are causes for concern. Ongoing education of both physicians and the public is essential, given that most episodes of upper and lower respiratory tract infections do not require antibiotic therapy. A public health policy on appropriate prescribing must be a priority and the ethics of promoting antibiotics in clinical settings where they are unnecessary should be given serious consideration. 4 Meanwhile, we suggest that a low seasonal fluctuation in fluoroquinolone prescribing is a good marker of restrained use. Sir, In the Journal of Antimicrobial Chemotherapy 1997; 40 745-6, I published a letter to the editor describing two cases and suggesting that the two patients failed to respond to once-daily vancomycin dosing.
Retraction
In the interest of encapsulating two highly complex cases in a brief letter to the editor, certain liberties were taken with the representation of data, which may have served to mislead.
Although this was not my intent, I nonetheless wish to retract this letter to the editor.
